Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts By Watertime - March 12, 2026 4 Post Content RELATED ARTICLESMORE FROM AUTHOR Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy
